French Open champion Iga Swiatek escaped with a one-month suspension for a positive doping test after convincing the International Tennis Integrity Agency that it had not been intentional, the ITIA announced on Thursday. Poland's Swiatek, 23, tested positive for the prohibited substance trimetazidine (TMZ) in an out-of-competition sample in August 2024. The ITIA, however, accepted that it was caused by "the contamination of a regulated non-prescription medication (melatonin), manufactured and sold in Poland that the player had been taking for jet lag and sleep issues".